Why the study?
The clinical impact of tricuspid regurgitation in patients after AMI was largely unknown.
Does the presence of mild or greater tricuspid regurgitation at discharge predict MACE in patients with first-onset AMI treated with primary PCI?
Does the presence of mild or greater tricuspid regurgitation at discharge predict MACE in patients with first-onset AMI treated with primary PCI?
Answers are grounded in this paper and cite their sources.
Mild or greater tricuspid regurgitation at discharge serves as a poor prognostic marker for MACE in patients with first-onset AMI treated with primary PCI.
AIMS: The clinical impact of tricuspid regurgitation (TR) in patients after acute myocardial infarction (AMI) is largely unknown. The aim of this study was to clarify the prevalence and prognostic impact of TR in post-AMI patients treated with appropriate primary percutaneous coronary intervention (PCI). METHODS AND RESULTS: ), reduced left ventricular ejection fraction (<50%) and the presence of significant (≥mild) ischaemic mitral regurgitation as independent predictors of mild or greater residual TR after primary PCI for AMI at discharge. Following adjustment for significant clinical parameters, mild or greater TR at discharge was still associated with a significant hazard ratio for the occurrence of MACE (1.87, [95% confidence interval, 1.01-3.48]; P = 0.048). CONCLUSIONS: The presence of mild or greater TR at discharge may serve as a poor prognostic marker in patients with first-onset AMI. In addition to traditional clinical risk factors, it is important to pay more attention to TR and to manage it appropriately.
No takes yet. Share an insight, caveat, or question.
Nishino et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: